ERBB2 and breast cancer: We classified intrinsic molecular subtypes for the BC cohorts using three methods—ER and HER2 immunohistochemistry (IHC) analyses, gene expression classifier (PAM50) and a naïve molecular classifier (NMC) based on ESR1, PGR, ERBB2 gene expression and ERBB2 copy number data.